相似文献
1
Neurohumoral and inflammatory activation in patients with coronary artery disease treated with statins.
Heart. 2006 Dec;92(12):1858-9. doi: 10.1136/hrt.2005.084368.
2
Statins targeting inflammation by lowering low-density lipoprotein?
J Am Coll Cardiol. 2007 May 22;49(20):2010-2. doi: 10.1016/j.jacc.2007.03.011. Epub 2007 May 4.
3
Effects of statin therapy on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials.
Arch Med Res. 2010 Aug;41(6):464-71. doi: 10.1016/j.arcmed.2010.08.009.
4
The use over time of statins in coronary patients in an Italian tertiary referral center.
Ital Heart J. 2001 Nov;2(11):848-53.
5
Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
J Am Coll Cardiol. 2006 Jan 17;47(2):338-41. doi: 10.1016/j.jacc.2005.06.087. Epub 2005 Dec 20.
6
[C-reactive protein and coronary heart disease: quo vadis?].
MMW Fortschr Med. 2009 Oct;151 Suppl 3:127-32.
7
Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation.
Am J Cardiol. 2008 Jan 15;101(2):199-202. doi: 10.1016/j.amjcard.2007.07.063.
8
9
The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
Am J Cardiol. 2005 Dec 15;96(12):1699-704. doi: 10.1016/j.amjcard.2005.07.092. Epub 2005 Oct 28.
10
Early effects of statins in patients with coronary artery disease and high C-reactive protein.
Am J Cardiol. 2004 Nov 1;94(9):1107-12. doi: 10.1016/j.amjcard.2004.07.074.
引用本文的文献
1
Association between Periodontopathogens and CRP Levels in Patients with Periodontitis in Serbia.
J Dent Res Dent Clin Dent Prospects. 2011 Winter;5(1):10-6. doi: 10.5681/joddd.2011.003. Epub 2011 Mar 18.
2
C-reactive protein as a systemic marker of inflammation in periodontitis.
Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):407-14. doi: 10.1007/s10096-010-1101-1. Epub 2010 Nov 6.
本文引用的文献
1
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
J Am Coll Cardiol. 2005 Oct 18;46(8):1417-24. doi: 10.1016/j.jacc.2005.08.024.
2
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
N Engl J Med. 2005 Jan 6;352(1):29-38. doi: 10.1056/NEJMoa042000.
3
C-reactive protein levels and outcomes after statin therapy.
N Engl J Med. 2005 Jan 6;352(1):20-8. doi: 10.1056/NEJMoa042378.
4
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
N Engl J Med. 2002 Nov 14;347(20):1557-65. doi: 10.1056/NEJMoa021993.
Zotero 插件